All Episodes

Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy?

Management of Rare Kidney Tumors

Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation?

NanoString Treatment for Kidney Cancer

Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

How is the Heng Criteria Applied to Kidney Cancer Patients?

Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment?

What is PD1 and PDL1 in Kidney Cancer?

Zykadia for ALK Positive Lung Cancer: New Drug, New Hope

No Clear Answer for Non-Clear Cell Kidney Cancer

What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer

Treating Newly Diagnosed Kidney Cancer

MET-Amplified Lung Cancer: A New Target for XALKORI?

The Hottest Thing in Late Stage Kidney Cancer

CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer

The Promise of PD1 Inhibitors in Kidney Cancer

FGFR and Its Role in Treating Squamous Cell Lung Cancer

AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer

What Are Heat Shock Protein (HSP) 90 Inhibitors and How May They Help Fight Lung Cancer?

What Is Non-Clear Cell Kidney Cancer?

The Promise of Immunotherapy in Lung Cancer

Does Gilotrif Help EGFR Positive Lung Cancer Patients?

Is Progression-Free Survival Meaningful?

DDR2 Mutations in Squamous Cell Lung Cancer

Does Adding Avastin to Tarceva Help EGFR Positive Lung Cancer Patients?

What is FGFR, and Could It Be a Valuable Target for Patients with Lung Cancer?

How Do We Make EGFR Inhibitors Work Better for Patients

TH 302: New Drug May Make Tumors Less Resistant to Treatment

Should We Do Broad Sequencing of All Lung Tumors?

How Do the New ALK Inhibitor Drugs Compare to Xalkori (Crizotinib) for ALK+ Lung Cancer Patients?

Why Are Non-Mutated EGFR Genes Called "Wild Type?"

Teaching the Immune System to Attack Lung Cancer Tumors

Advice for Lung Cancer Patients: Know Thy Cancer

Is It Necessary for Early Stage Lung Cancer Patients to Get Molecular Testing for Their Tumors?

Treating EGFR Patients After Tarceva Stops Working

Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive Non-small Cell Lung Cancer?

An Update on ECOG 1505: Will Avastin (Bevacizumab) Become Standard Treatment for Early Stage Lung Cancer Patients?

Targeted Treatment for Lung Cancer After Progression

Can Vaccines Fight Lung Cancer?

CO-1686, a Third Generation Drug for EGFR Positive Lung Cancer Patients

Why Do We Call Them "Small Cell Lung Cancer" and "Non-Small Cell Lung Cancer"?

Targeting the RAF Pathway in Lung Cancer

Is It Possible to Test Lung Tumors Without Doing a Biopsy?

What Are PARP Inhibitors, and Might They Improve Outcomes in Small Cell Lung Cancer?

New Insights into Small Cell Lung Cancer

In What Clinical Setting Should Immunotherapies Be Developed?

Maintenance Therapy in Small Cell Lung Cancer

LDE225 and Small Cell Lung Cancer

Is There a Silver Bullet for Small Cell Lung Cancer?

Advice for Newly Diagnosed Small Cell Lung Cancer Patients

PARP Inhibitors in Small Cell Lung Cancer

What's the Status and Potential Utility of Cabozantinib in Lung Cancer?

MK-3475 and its Efficacy in Lung Cancer

How Do the Different Immune Checkpoint Inhibitors in Lung Cancer Compare?

Do you see PARP inhibitors as a single drug therapy or more in a combination setting?

Late Stage Oropharynx Cancer, Chemotherapy - Options and Practice (video)

Late Stage Oropharynx Cancer, Chemotherapy - Options and Practice (audio)

ALK Positive Lung Cancer Forum 2014: Repeat Biopsies

ALK Positive Lung Cancer Forum 2014: Next Generation ALK Inhibitors

ALK Positive Lung Cancer Forum 2014: Disease Progression While on Xalkori

ALK Positive Lung Cancer Forum 2014: Scanning for Progression

ALK Positive Lung Cancer Forum 2014: Risk of Flare After Stopping Targeted Therapy

ALK Positive Lung Cancer Forum 2014: Can I Pass ALK Onto My Children

ALK Positive Lung Cancer Forum 2014: Testing for ALK

ALK Positive Lung Cancer Forum 2014: Xalkori

ALK Positive Lung Cancer Forum 2014: ALK Rearrangements in Lung Cancer

Late Stage Oropharynx Cancer, Treatment and Side Effects (video)

Late Stage Oropharynx Cancer, Treatment and Side Effects (audio)

Late Stage Oropharynx Cancer, Planning for External Beam Radiotherapy (video)

Late Stage Oropharynx Cancer, Planning for External Beam Radiotherapy (audio)

Late Stage Oropharynx Cancer, Introduction and Management (video)

Late Stage Oropharynx Cancer, Introduction and Management (audio)

Squamous Lung Cancer Part 5, Q and A Session (video)

Squamous Lung Cancer Part 5, Q and A Session (audio)

Squamous Lung Cancer, Part 4: Immunotherapy (video)

Squamous Lung Cancer, Part 4: Immunotherapy (audio)

Squamous Lung Cancer, Part 3: Treatment (video)

Squamous Lung Cancer, Part 3: Treatment (audio)

Squamous Lung Cancer, Part 2: Genomic Testing (video)

Squamous Lung Cancer, Part 2: Genomic Testing (audio)

Squamous Lung Cancer, Part 1: Diagnosis, Presentation and Workup (video)

Squamous Lung Cancer, Part 1: Diagnosis, Presentation and Workup (audio)

Chemotherapy for Pancreatic Cancer, Part 6: Moving Forward in Advanced Pancreatic Cancer (audio)

Chemotherapy for Pancreatic Cancer, Part 6: Moving Forward in Advanced Pancreatic Cancer (video)

Chemotherapy for Pancreatic Cancer, Part 5: Chemotherapy for Metastatic Pancreatic Cancer (video)

Chemotherapy for Pancreatic Cancer, Part 5: Chemotherapy for Metastatic Pancreatic Cancer (audio)

Chemotherapy for Pancreatic Cancer, Part 4: Post-Operative (Adjuvant) Treatment for Pancreatic Cancer (video)

Chemotherapy for Pancreatic Cancer, Part 4: Post-Operative (Adjuvant) Treatment for Pancreatic Cancer (audio)

Chemotherapy for Pancreatic Cancer, Part 3: Pre-Operative Treatment for Pancreatic Cancer (video)

Chemotherapy for Pancreatic Cancer, Part 3: Pre-Operative Treatment for Pancreatic Cancer (audio)

Chemotherapy for Pancreatic Cancer, Part 2: Resectable vs. Unresectable Pancreatic Cancer (video)

Chemotherapy for Pancreatic Cancer, Part 2: Resectable vs. Unresectable Pancreatic Cancer (audio)

ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (video)

ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)

ASCO Lung Cancer Highlights, Part 12: Ganetespib with Second Line Chemotherapy for Advanced NSCLC (video)

ASCO Lung Cancer Highlights, Part 12: Ganetespib with Second Line Chemotherapy for Advanced NSCLC (audio)

ASCO Lung Cancer Highlights, Part 11: Nintedanib with Second Line Chemotherapy for Advanced NSCLC (video)

ASCO Lung Cancer Highlights, Part 11: Nintedanib with Second Line Chemotherapy for Advanced NSCLC (audio)

ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC (video)

ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC (audio)